Mark Rosenblatt MD PhD MBA MHA

Summary

• Dr. Rosenblatt is a clinician scientist with interest in corneal regenerative medicine. He received his MD and PhD from the University of Miami School of Medicine and then completed a residency in ophthalmology and a clinical/research fellowship in corneal disease at Harvard Medical School. While at Cornell University, he was a member of the steering committee embarking on the T32 Vision Science Training Program. At UIC, the Rosenblatt laboratory is involved in the development of novel regenerative treatments for ocular surface and corneal disease, including programs in ocular surface tissue engineering, corneal epithelial stem cells, and the repair of corneal nerves and sensation after injury. Dr. Rosenblatt has embarked upon an ocular surface tissue-engineering project which uses surface modified silk films to optimize outcomes of ocular surface reconstruction. He utilizes basic cell and molecular biology techniques to characterize the response of cells to these materials and then translates these findings to clinically relevant models of corneal disease as a prelude to potential adaptation to treat patients with potentially blinding corneal disease. Many of Dr. Rosenblatt's research endeavors includes training his fellows and residents, as well as graduate students in bioengineering and neuro-science. He is also the Associate Director of the MSTP program at UIC.